4Mountain C F. Revisions in the international system for staging lung Cancer [J]. Chest, 1997, 111 (6): 1710.
5Johnson J R, Temple R. Food and Drug Administration requirements for approval of new anti-cancer drugs [J]. Cancer Treat Rep, 1985,69: 1155.
6Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase Ⅱ trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer [ J]. J Clin Oncol, 2003, 21:2237.
7Hilsenbeck SG,Raub WA Jr,Sridhar KS:Prognostic factors in lung cancer based on multivariate analysis[J].Am J Clin Oncol,1993(16):301-309
8Ries LA:Influence of extent of disease,histology,and demographic factors on lung cancer survival in the SEER population-based data[J].Semin Surg Oncol,1994(10):21-30
9Stanley KE.Prognostic factors for survival in patients with inoperable lung cancer[J].J Natl Cancer Inst,1980,65(1):25-32
10María Remedios Alemán,Francisco Santolaria,et al.Leptin role in advanced lung cancer.A mediator of the acute response or a marker of the status of nutrition[J].Cytokine,2002,19(1):21-26
